Clinical Trial

A Phase I Clinical Trial Evaluating the Safety, Tolerability and Pharmacokinetics of AAPB for Injection

Study acronym: AAPB
Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated November 8, 2024 (before its estimated January 12, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a Phase I clinical to evaluate the safety and tolerability of single and multiple intravenous infusions of AAPB at different doses over 7 consecutive days.
Trial Details
NCT Number NCT06679998
Lead Sponsor Jiangsu Kanion Pharmaceutical Co., Ltd
Conditions Acute Ischemic Stroke (AIS)
Enrollment 56 participants
Start Date 2024-11-14
Primary Completion 2026-01-12 (estimated)
Study Completion 2026-03-26 (estimated)
Updated on ClinicalTrials.gov 2024-11-08